| PERIOD ENDING | 12-Sep-09 | 20-Jun-09 | 28-Mar-09 | 3-Jan-09 | | Total Revenue | 610,222 | 596,027 | 581,254 | 781,949 | | Cost of Revenue | 474,209 | 465,013 | 445,629 | 624,509 | | | Gross Profit | 136,013 | 131,014 | 135,625 | 157,440 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 115,575 | 115,322 | 118,326 | 139,552 | | Non Recurring | (601) | 601 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 21,039 | 15,091 | 17,299 | 17,888 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 30 | 23 | (10) | 142 | | Earnings Before Interest And Taxes | 21,069 | 15,114 | 17,289 | 18,030 | | Interest Expense | 3,727 | 3,663 | 2,922 | 3,216 | | Income Before Tax | 17,342 | 11,451 | 14,367 | 14,814 | | Income Tax Expense | 6,845 | 4,607 | 5,704 | 6,132 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 10,497 | 6,844 | 8,663 | 8,682 | | | Non-recurring Events | | Discontinued Operations | (63) | 15 | 230 | 229 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 10,434 | 6,859 | 8,893 | 8,911 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $10,434 | $6,859 | $8,893 | $8,911 |
|
0.31% Nasdaq 
0.05%
Income Statement
